These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 24363796)

  • 1. Functional characterization of a novel frameshift mutation in the C-terminus of the Nav1.5 channel underlying a Brugada syndrome with variable expression in a Spanish family.
    Dolz-Gaitón P; Núñez M; Núñez L; Barana A; Amorós I; Matamoros M; Pérez-Hernández M; González de la Fuente M; Alvarez-López M; Macías-Ruiz R; Tercedor-Sánchez L; Jiménez-Jáimez J; Delpón E; Caballero R; Tamargo J
    PLoS One; 2013; 8(11):e81493. PubMed ID: 24363796
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Complex interactions in a novel SCN5A compound mutation associated with long QT and Brugada syndrome: Implications for Na+ channel blocking pharmacotherapy for de novo conduction disease.
    Liu J; Bayer JD; Aschar-Sobbi R; Wauchop M; Spears D; Gollob M; Vigmond EJ; Tsushima R; Backx PH; Chauhan VS
    PLoS One; 2018; 13(5):e0197273. PubMed ID: 29791480
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reduced current density, partially rescued by mexiletine, and depolarizing shift in activation of SCN5A W374G channels as a cause of severe form of Brugada syndrome.
    Nakajima T; Dharmawan T; Kawabata-Iwakawa R; Tamura S; Hasegawa H; Kobari T; Ota M; Tange S; Nishiyama M; Kaneko Y; Kurabayashi M
    Ann Noninvasive Electrocardiol; 2021 May; 26(3):e12828. PubMed ID: 33463855
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Variable Penetrance and Expressivity of a Rare Pore Loss-of-Function Mutation (p.L889V) of Nav1.5 Channels in Three Spanish Families.
    Gallego-Delgado M; Cámara-Checa A; Rubio-Alarcón M; Heredero-Jung D; de la Fuente-Blanco L; Rapún J; Plata-Izquierdo B; Pérez-Martín S; Cebrián J; Moreno de Redrojo L; García-Berrocal B; Delpón E; Sánchez PL; Villacorta E; Caballero R
    Int J Mol Sci; 2024 Apr; 25(9):. PubMed ID: 38731905
    [TBL] [Abstract][Full Text] [Related]  

  • 5. p.D1690N Nav1.5 rescues p.G1748D mutation gating defects in a compound heterozygous Brugada syndrome patient.
    Núñez L; Barana A; Amorós I; de la Fuente MG; Dolz-Gaitón P; Gómez R; Rodríguez-García I; Mosquera I; Monserrat L; Delpón E; Caballero R; Castro-Beiras A; Tamargo J
    Heart Rhythm; 2013 Feb; 10(2):264-72. PubMed ID: 23085483
    [TBL] [Abstract][Full Text] [Related]  

  • 6. De Novo Mutation in the SCN5A Gene Associated with Brugada Syndrome.
    Wang L; Meng X; Yuchi Z; Zhao Z; Xu D; Fedida D; Wang Z; Huang C
    Cell Physiol Biochem; 2015; 36(6):2250-62. PubMed ID: 26279430
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Functional Characterization of Two Novel Mutations in
    Balla C; Conte E; Selvatici R; Marsano RM; Gerbino A; Farnè M; Blunck R; Vitali F; Armaroli A; Brieda A; Liantonio A; De Luca A; Ferlini A; Rapezzi C; Bertini M; Gualandi F; Imbrici P
    Int J Mol Sci; 2021 Jun; 22(12):. PubMed ID: 34204499
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mexiletine rescues a mixed biophysical phenotype of the cardiac sodium channel arising from the SCN5A mutation, N406K, found in LQT3 patients.
    Hu RM; Tester DJ; Li R; Sun T; Peterson BZ; Ackerman MJ; Makielski JC; Tan BH
    Channels (Austin); 2018; 12(1):176-186. PubMed ID: 29983085
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of a novel Nav1.5 channel mutation, A551T, associated with Brugada syndrome.
    Chiang KC; Lai LP; Shieh RC
    J Biomed Sci; 2009 Aug; 16(1):76. PubMed ID: 19706159
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Enhanced closed-state inactivation of mutant cardiac sodium channels (SCN5A N1541D and R1632C) through different mechanisms.
    Dharmawan T; Nakajima T; Iizuka T; Tamura S; Matsui H; Kaneko Y; Kurabayashi M
    J Mol Cell Cardiol; 2019 May; 130():88-95. PubMed ID: 30935997
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Enhanced fast-inactivated state stability of cardiac sodium channels by a novel voltage sensor SCN5A mutation, R1632C, as a cause of atypical Brugada syndrome.
    Nakajima T; Kaneko Y; Saito A; Ota M; Iijima T; Kurabayashi M
    Heart Rhythm; 2015 Nov; 12(11):2296-304. PubMed ID: 26031372
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Novel SCN5A mutations in two families with "Brugada-like" ST elevation in the inferior leads and conduction disturbances.
    Maury P; Moreau A; Hidden-Lucet F; Leenhardt A; Fressart V; Berthet M; Denjoy I; Bennamar N; Rollin A; Cardin C; Guicheney P; Chahine M
    J Interv Card Electrophysiol; 2013 Aug; 37(2):131-40. PubMed ID: 23612926
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization and mechanisms of action of novel NaV1.5 channel mutations associated with Brugada syndrome.
    Calloe K; Refaat MM; Grubb S; Wojciak J; Campagna J; Thomsen NM; Nussbaum RL; Scheinman MM; Schmitt N
    Circ Arrhythm Electrophysiol; 2013 Feb; 6(1):177-84. PubMed ID: 23424222
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Trafficking and Gating Cooperation Between Deficient Na
    Clatot J; Coulombe A; Deschênes I; Guicheney P; Neyroud N
    Front Biosci (Landmark Ed); 2022 Jun; 27(7):209. PubMed ID: 35866404
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Beneficial effects of chronic mexiletine treatment in a human model of SCN5A overlap syndrome.
    Nasilli G; Yiangou L; Palandri C; Cerbai E; Davis RP; Verkerk AO; Casini S; Remme CA
    Europace; 2023 Jun; 25(6):. PubMed ID: 37369559
    [TBL] [Abstract][Full Text] [Related]  

  • 16. SCN5A(K817E), a novel Brugada syndrome-associated mutation that alters the activation gating of NaV1.5 channel.
    Kinoshita K; Takahashi H; Hata Y; Nishide K; Kato M; Fujita H; Yoshida S; Murai K; Mizumaki K; Nishida K; Yamaguchi Y; Kano M; Tabata T; Nishida N
    Heart Rhythm; 2016 May; 13(5):1113-1120. PubMed ID: 26776555
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A heterozygous deletion mutation in the cardiac sodium channel gene SCN5A with loss- and gain-of-function characteristics manifests as isolated conduction disease, without signs of Brugada or long QT syndrome.
    Zumhagen S; Veldkamp MW; Stallmeyer B; Baartscheer A; Eckardt L; Paul M; Remme CA; Bhuiyan ZA; Bezzina CR; Schulze-Bahr E
    PLoS One; 2013; 8(6):e67963. PubMed ID: 23840796
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A mutation causing Brugada syndrome identifies a mechanism for altered autonomic and oxidant regulation of cardiac sodium currents.
    Aiba T; Farinelli F; Kostecki G; Hesketh GG; Edwards D; Biswas S; Tung L; Tomaselli GF
    Circ Cardiovasc Genet; 2014 Jun; 7(3):249-56. PubMed ID: 24795344
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Zfhx3 Transcription Factor Represses the Expression of
    Rubio-Alarcón M; Cámara-Checa A; Dago M; Crespo-García T; Nieto-Marín P; Marín M; Merino JL; Toquero J; Salguero-Bodes R; Tamargo J; Cebrián J; Delpón E; Caballero R
    Int J Mol Sci; 2021 Dec; 22(23):. PubMed ID: 34884836
    [TBL] [Abstract][Full Text] [Related]  

  • 20. GPD1L-A306del modifies sodium current in a family carrying the dysfunctional SCN5A-G1661R mutation associated with Brugada syndrome.
    Semino F; Darche FF; Bruehl C; Koenen M; Skladny H; Katus HA; Frey N; Draguhn A; Schweizer PA
    Pflugers Arch; 2024 Feb; 476(2):229-242. PubMed ID: 38036776
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.